According to Agenus 's latest financial reports the company's current earnings (TTM) are -$0.17 B. a decrease over its 2021 earnings that were of $36.99 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2022 | -$0.17 B | -556.26% |
2021 | $36.99 M | -130.37% |
2020 | -$0.13 B | 73.75% |
2019 | -$70.11 M | -48.74% |
2018 | -$0.14 B | 26.98% |
2017 | -$0.11 B | 2.07% |
2016 | -$0.11 B | 42.6% |
2015 | -$74 M | 106.5% |
2014 | -$35.84 M | 43.45% |
2013 | -$24.98 M | |
2011 | -$19.09 M | -12.25% |
2010 | -$21.76 M | -21.41% |
2009 | -$27.68 M | -26.86% |
2008 | -$37.85 M | 13.72% |
2007 | -$33.28 M | -33.4% |
2006 | -$49.97 M | -32.4% |
2005 | -$73.92 M | 9.03% |
2004 | -$67.8 M | 0.08% |
2003 | -$67.74 M | 18.06% |
2002 | -$57.38 M | 37.83% |
2001 | -$41.63 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $24.48 B | -14,606.44% | ๐บ๐ธ USA |
![]() Merck MRK | $16.46 B | -9,855.09% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $8.79 B | -5,311.09% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $6.55 B | -3,980.69% | ๐ฌ๐ง UK |
![]() Celldex Therapeutics CLDX | -$0.12 B | -31.41% | ๐บ๐ธ USA |